Biological screening for anti-influenza a virus agents / Tan Ming Cheang
Influenza virus is estimated to cause 3-5 million severe complications and about 250- 500 thousand deaths per year. Different kinds of anti-influenza virus drugs have been developed. However, the emergence of drug resistant strains has presented a big challenge for efficient antiviral therapy. In...
| Main Author: | |
|---|---|
| Format: | Thesis |
| Published: |
2018
|
| Subjects: | |
| Online Access: | http://studentsrepo.um.edu.my/9410/ http://studentsrepo.um.edu.my/9410/1/Tan_Ming_Cheang.pdf http://studentsrepo.um.edu.my/9410/8/ming_cheang.pdf |
| Summary: | Influenza virus is estimated to cause 3-5 million severe complications and about 250-
500 thousand deaths per year. Different kinds of anti-influenza virus drugs have been
developed. However, the emergence of drug resistant strains has presented a big
challenge for efficient antiviral therapy. Indole derivatives have been shown to exhibit
both antiviral and anti-inflammatory activities. In this study, a cell-based system was
adopted to screen for potential anti-IAV agents. Four indole derivatives (named 525A,
526A, 527A and 528A) were subjected to the antiviral screening, of which 526A was
selected for further investigation. Here, pre-treating cells with 526A protects
adenocarcinomic human alveolar basal epithelial cells from IAV infection. Furthermore,
526A inhibits IAV replication by inhibiting the expression of IAV genes. Interestingly,
526A partially blocks the activation of RIG-I pathway and therefore suppresses the
activation of IRF3 and STAT1 in host cells and thus represses the production of type I
interferon response and cytokines in IAV-infected cells. Taken together, these results
suggest that 526A may be a potential anti-influenza A virus agent. |
|---|